News & Updates

Show Multimedia Only
Dimethyl fumarate bests interferon β-1a in paediatric-onset multiple sclerosis

Dimethyl fumarate bests interferon β-1a in paediatric-onset multiple sclerosis

10 Oct 2022

The use of dimethyl fumarate (DMF) in the treatment of children with paediatric-onset multiple sclerosis (POMS) appears to produce more favourable effects than interferon β-1a (IFNβ-1a), with those on DMF being less likely to have new or newly enlarging lesions and experience relapse, according to data from the open-label CONNECT study.

10 Oct 2022
SGLT2i does not worsen lower-limb amputation risk

SGLT2i does not worsen lower-limb amputation risk

10 Oct 2022

Among patients with type 2 diabetes (T2D), the use of sodium-glucose cotransporter 2 inhibitors {SGLT2i) does not appear to increase the risk of lower-limb amputation, a recent study has found.

10 Oct 2022